Display options
Share it on

Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul.

Hemostasis in Overt and Subclinical Hyperthyroidism.

International journal of endocrinology and metabolism

Arash Ordookhani, Kenneth D Burman

Affiliations

  1. Endocrine Section, Department of Internal Medicine, Providence Hospital, Washington, DC, 20017.
  2. Endocrine Section, MedStar Washington Hospital Center, Washington, DC, 20010.

PMID: 29201071 PMCID: PMC5702470 DOI: 10.5812/ijem.44157

Abstract

CONTEXT: There are contradictory results on the effect of hyperthyroidism on hemostasis. Inadequate population-based studies limited their clinical implications, mainly on the risk of venous thromboembolism (VTE). The present review focuses on hemostatic changes in overt and subclinical hyperthyroidism.

METHODS: A systematic literature search was conducted employing MEDLINE database. The following words were used for the search: Hyperthyroidism; thyrotoxicosis; Graves disease; goiter, nodular; hemostasis; blood coagulation factors; blood coagulation disorders; venous thromboembolism; bleeding; fibrinolysis. The articles that were related to hyperthyroidism and hemostasis are used in this manuscript.

RESULTS: Hyperthyroidism, either overt or subclinical, renders a hypercoagulable state, although there are several studies with contradictory findings in the literature. Hypercoagulability may be caused by an increase in the level of various coagulation factors such as factor (F) VIII, FX, FIX, von Willebrand F (vWF), and fibrinogen, while hypofibrinolysis by changes in coagulation parameters such as a decrease in plasmin and plasmin activator or an increase in α2-antiplasmin, plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor.

CONCLUSIONS: Although many reports are in favor of a hypercoagulable state in overt hyperthyroidism but this finding at the biochemical level and its clinical implication, on the occurrence of VTE, has yet to be confirmed.

Keywords: Autoimmune; Blood Coagulation Factors; Fibrinolysis; Hashimoto Disease; Hyperthyroidism; Hypothyroidism; Myxedema; Thyroid Neoplasms; Thyroiditis; Venous Thromboembolism

Conflict of interest statement

Conflict Of Interest:None to declare

References

  1. J Clin Endocrinol Metab. 2007 Jul;92(7):2415-20 - PubMed
  2. Thyroid. 2001 Feb;11(2):153-60 - PubMed
  3. Arch Intern Med. 2005 Nov 28;165(21):2467-72 - PubMed
  4. J Thromb Haemost. 2010 Jun;8(6):1427-8 - PubMed
  5. J Endocrinol Invest. 2002 Mar;25(3):246-9 - PubMed
  6. Thromb Haemost. 2012 Dec;108(6):1077-88 - PubMed
  7. Hematology Am Soc Hematol Educ Program. 2009;:255-8 - PubMed
  8. N Engl J Med. 2001 Feb 15;344(7):501-9 - PubMed
  9. J Clin Endocrinol Metab. 2012 May;97(5):1463-73 - PubMed
  10. Br J Cancer. 2009 Jun 16;100(12):1837-41 - PubMed
  11. BMC Med. 2011 Jan 10;9:1 - PubMed
  12. Endocrine. 2009 Dec;36(3):473-8 - PubMed
  13. J Clin Endocrinol Metab. 2000 Dec;85(12):4701-5 - PubMed
  14. Blood. 1991 Dec 15;78(12):3114-24 - PubMed
  15. Intern Emerg Med. 2015 Mar;10 (2):219-46 - PubMed
  16. Thromb Haemost. 1998 May;79(5):919-23 - PubMed
  17. Acta Haematol. 1980;63(4):185-90 - PubMed
  18. Ann Intern Med. 1982 Nov;97(5):713-6 - PubMed
  19. Nat Med. 2002 Oct;8(10):1175-81 - PubMed
  20. J Endocrinol Invest. 2006 Mar;29(3):197-200 - PubMed
  21. J Endocrinol Invest. 2002 Apr;25(4):345-50 - PubMed
  22. Thromb Diath Haemorrh. 1964 Jan 1;10:267-77 - PubMed
  23. Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9 - PubMed
  24. Neth J Med. 2014 May;72(4):242-4 - PubMed
  25. Lancet. 1973 Oct 20;2(7834):894-5 - PubMed
  26. J Endocrinol Invest. 1988 Nov;11(10):723-5 - PubMed
  27. Biol Rev Camb Philos Soc. 2000 Nov;75(4):519-631 - PubMed
  28. J Thromb Haemost. 2014 Jun;12(6):839-46 - PubMed
  29. Endocr J. 2007 Aug;54(4):593-9 - PubMed
  30. J Thromb Haemost. 2011 Sep;9(9):1816-24 - PubMed
  31. Eur J Endocrinol. 2002 May;146(5):607-11 - PubMed
  32. J Clin Endocrinol Metab. 2007 Aug;92(8):3006-12 - PubMed
  33. J Clin Endocrinol Metab. 2001 Feb;86(2):732-7 - PubMed
  34. Am Heart J. 1989 Apr;117(4):976-7 - PubMed
  35. Br Med J. 1967 Oct 28;4(5572):147-8 - PubMed
  36. N Engl J Med. 2008 Aug 28;359(9):938-49 - PubMed
  37. Ann Emerg Med. 1988 Nov;17(11):1138-47 - PubMed
  38. Endokrynol Pol. 2011;62(5):409-15 - PubMed
  39. Hematology. 2006 Jun;11(3):203-8 - PubMed
  40. J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
  41. J Thromb Thrombolysis. 2009 Oct;28(3):362-5 - PubMed
  42. Thromb Res. 2003 Jun 1;110(4):243-7 - PubMed
  43. Thromb Haemost. 2012 Mar;107(3):417-22 - PubMed
  44. JAMA. 2006 Mar 1;295(9):1033-41 - PubMed
  45. Semin Thromb Hemost. 2009 Apr;35(3):288-94 - PubMed
  46. J Lab Clin Med. 1988 Jul;112(1):58-67 - PubMed
  47. J Clin Endocrinol Metab. 1993 Mar;76(3):609-14 - PubMed
  48. J Clin Endocrinol Metab. 2004 Sep;89(9):4469-73 - PubMed
  49. Eur J Clin Invest. 1998 Dec;28(12):1050-4 - PubMed
  50. Semin Thromb Hemost. 2013 Jul;39(5):489-95 - PubMed
  51. Blood Coagul Fibrinolysis. 2007 Dec;18(8):801-3 - PubMed
  52. J Clin Endocrinol Metab. 2006 Feb;91(2):530-4 - PubMed
  53. J Thromb Haemost. 2015 Jun;13 Suppl 1:S200-7 - PubMed
  54. Eur Neurol. 2005;54(2):78-80 - PubMed
  55. Saudi Med J. 2008 Sep;29(9):1289-93 - PubMed
  56. J Endocrinol Invest. 2004 Dec;27(11):1065-71 - PubMed
  57. JAMA. 1975 Mar 17;231(11):1165-6 - PubMed
  58. Q J Med. 1986 Jan;58(225):43-51 - PubMed
  59. Neth J Med. 1999 Oct;55(4):201-2 - PubMed
  60. J Endocrinol Invest. 2004 Oct;27(9):886-92 - PubMed
  61. J Thromb Haemost. 2010 Oct;8(10):2176-81 - PubMed
  62. Thyroid. 2000 Jul;10 (7):607-10 - PubMed
  63. Acta Endocrinol (Copenh). 1992 May;126(5):399-403 - PubMed
  64. Thyroid. 1996 Jun;6(3):245-7 - PubMed
  65. Metabolism. 1987 Jun;36(6):562-9 - PubMed
  66. Med Sci Monit. 2008 Jan;14(1):CR42-46 - PubMed
  67. J Clin Endocrinol Metab. 2005 Jan;90(1):581-5; discussion 586-7 - PubMed
  68. Thromb Haemost. 1992 Jun 1;67(6):729 - PubMed
  69. Int J Endocrinol. 2013;2013:981638 - PubMed
  70. Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):381-7 - PubMed
  71. Ann Intern Med. 1992 Jan 1;116(1):1-5 - PubMed
  72. Int J Cardiol. 2008 Mar 28;125(1):41-8 - PubMed
  73. Clin Appl Thromb Hemost. 2009 Dec;15(6):676-80 - PubMed
  74. J Clin Endocrinol Metab. 1990 Feb;70(2):491-6 - PubMed
  75. Ir Med J. 2003 Feb;96(2):46-7 - PubMed
  76. Endocrinology. 2004 Jun;145(6):2804-14 - PubMed
  77. Arch Intern Med. 2007 Jul 23;167(14):1526-32 - PubMed
  78. Am J Emerg Med. 2008 Mar;26(3):383.e1-2 - PubMed
  79. Eur J Endocrinol. 1997 Jan;136(1):1-7 - PubMed
  80. Semin Thromb Hemost. 2011 Feb;37(1):7-10 - PubMed
  81. Int J Clin Pract. 2003 Mar;57(2):78-81 - PubMed
  82. Endocrine. 2009 Aug;36(1):110-8 - PubMed
  83. Stroke. 1995 Mar;26(3):496-7 - PubMed
  84. J Thromb Haemost. 2012 Aug;10(8):1539-46 - PubMed
  85. J Biol Chem. 1987 Jun 25;262(18):8443-6 - PubMed
  86. Handb Exp Pharmacol. 2006;(176 Pt 2):1-41 - PubMed
  87. Thromb Haemost. 1976 Apr 30;35(2):415-22 - PubMed
  88. J Intern Med. 1995 Jul;238(1):59-63 - PubMed
  89. Blood. 2010 Jun 3;115(22):4344-9 - PubMed
  90. Eur J Endocrinol. 2015 May;172(5):537-42 - PubMed
  91. N Engl J Med. 1965 Nov 11;273(20):1057-61 - PubMed
  92. Stroke. 2005 Oct;36(10):2302-10 - PubMed
  93. Med Princ Pract. 2011;20(1):23-8 - PubMed

Publication Types